New drug reduces risk by 65% The new drug Exemestane that is sold under the name Aromasin will help reduce the risk of tumors by almost 65% in post-menopausal women who are at a risk of developing breast cancer. The drug is presently used to treat breast cancer and does not have the huge side Read more